REPORTS

Let’s Pullulate and Expand Your Business

Subcutaneous Infusion Devices Market - Global Professional Analysis and Forecast to 2026

Oct 12, 2019  |  158 PAGES  |  REPORT CODE: CMM205782
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Subcutaneous Infusion Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.0% during the forecast period.

This report presents the market size and development trends by detailing the Subcutaneous Infusion Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Subcutaneous Infusion Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Subcutaneous Infusion Devices industry and will help you to build a panoramic view of the industrial development.

Subcutaneous Infusion Devices Market, By Type:

  • Electricity driven

  • Electrochemical gas driven

  • Osmosis driven

  • Spring driven

  • Elastomeric driven

  • Chemical gas driven

Subcutaneous Infusion Devices Market, By Application:

  • Hospital

  • Clinic

Some of the leading players are as follows:

  • Novartis International AG

  • Amedra Pharmaceuticals

  • Pfizer

  • Bayer AG

  • Emerade

  • ALK Abello

  • Emergent BioSolutions

  • Owen Mumford

  • Unilife Corporation

  • Biogen Idec, Inc

  • Ypsomed Holding AG

  • Sanofi S. A

  • Sanofi

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Subcutaneous Infusion Devices Market: Technology Type Analysis

  • 4.1 Subcutaneous Infusion Devices Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Subcutaneous Infusion Devices Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Electricity driven

    • 4.3.2 Electrochemical gas driven

    • 4.3.3 Osmosis driven

    • 4.3.4 Spring driven

    • 4.3.5 Elastomeric driven

    • 4.3.6 Chemical gas driven

5 Subcutaneous Infusion Devices Market: Product Analysis

  • 5.1 Subcutaneous Infusion Devices Product Market Share Analysis, 2018 & 2026

  • 5.2 Subcutaneous Infusion Devices Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Subcutaneous Infusion Devices Market: Application Analysis

  • 6.1 Subcutaneous Infusion Devices Application Market Share Analysis, 2018 & 2026

  • 6.2 Subcutaneous Infusion Devices Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital

    • 6.3.2 Clinic

7 Subcutaneous Infusion Devices Market: Regional Analysis

  • 7.1 Subcutaneous Infusion Devices Regional Market Share Analysis, 2018 & 2026

  • 7.2 Subcutaneous Infusion Devices Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Novartis International AG

    • 9.1.1 Novartis International AG Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Amedra Pharmaceuticals

    • 9.2.1 Amedra Pharmaceuticals Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Pfizer

    • 9.3.1 Pfizer Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Bayer AG

    • 9.4.1 Bayer AG Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Emerade

    • 9.5.1 Emerade Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 ALK Abello

    • 9.6.1 ALK Abello Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Emergent BioSolutions

    • 9.7.1 Emergent BioSolutions Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Owen Mumford

    • 9.8.1 Owen Mumford Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Unilife Corporation

    • 9.9.1 Unilife Corporation Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Biogen Idec, Inc

    • 9.10.1 Biogen Idec, Inc Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Ypsomed Holding AG

    • 9.11.1 Ypsomed Holding AG Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Sanofi S. A

    • 9.12.1 Sanofi S. A Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Sanofi

    • 9.13.1 Sanofi Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

 

The List of Tables and Figures (Totals 104 Figures and 130 Tables)

  • Figure Electricity driven Subcutaneous Infusion Devices market, 2015 - 2026 (USD Million)

  • Figure Electrochemical gas driven Subcutaneous Infusion Devices market, 2015 - 2026 (USD Million)

  • Figure Osmosis driven Subcutaneous Infusion Devices market, 2015 - 2026 (USD Million)

  • Figure Spring driven Subcutaneous Infusion Devices market, 2015 - 2026 (USD Million)

  • Figure Elastomeric driven Subcutaneous Infusion Devices market, 2015 - 2026 (USD Million)

  • Figure Chemical gas driven Subcutaneous Infusion Devices market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Subcutaneous Infusion Devices market, by country, 2015 - 2026 (USD Million)

  • Table North America Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table North America Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table North America Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Canada Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Canada Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Europe Subcutaneous Infusion Devices market, by country, 2015 - 2026 (USD Million)

  • Table Europe Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Europe Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Europe Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Germany Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Germany Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table France Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table France Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Italy Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Italy Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Spain Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Spain Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Subcutaneous Infusion Devices market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table China Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table China Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Japan Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Japan Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table India Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table India Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Subcutaneous Infusion Devices market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table MEA Subcutaneous Infusion Devices market, by country, 2015 - 2026 (USD Million)

  • Table MEA Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table MEA Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table MEA Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Subcutaneous Infusion Devices market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Subcutaneous Infusion Devices market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Subcutaneous Infusion Devices market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Novartis International AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amedra Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emerade Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ALK Abello Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emergent BioSolutions Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Owen Mumford Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Unilife Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biogen Idec, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ypsomed Holding AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi S. A Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top